Stocks
FibroGen (FGEN) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -288.5 | -282.8 | -305.2 | -142.4 | -45.9 | -45.9 | ||
| Changes by years, y/y, % | -14% | -2% | +8% | -53% | -68% | -22.5% | |||
FibroGen. EBITDA US GAAP, bln rub
FibroGen. EBITDA US GAAP, changes, %
FibroGen. EBITDA US GAAP, sum by quarters, bln rub
FibroGen (FGEN) EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EBITDA, bln rub | ? | -91.1 | -14.2 | -11.5 | -10.9 | -9.30 | -45.9 | |
| Changes by years, y/y, % | +83% | -71% | -75% | -11% | -90% | |||
| Changes by quarters, q/q, % | +644% | -84% | -19% | -6% | -14% | |||
